TREATMENT PHARMA ApS: Financial statements 2022
CVR: 37208035
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
TREATMENT PHARMA ApS (CVR 37208035) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -22,856 and a net result of DKK -23,841 compared with DKK -2,623 the year before. Equity in the 2022 report amounted to DKK -29,002.
- Gross Profit
- DKK -22,856
- Profit/Loss
- DKK -23,841
- Equity
- DKK -29,002
- Total Assets
- DKK 221,696
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -23 t. | -24 t. | -29 t. | - |
| 2021 | - | -3 t. | -3 t. | -5 t. | - |
| 2020 | - | -3 t. | 163 t. | -3 t. | - |
| 2019 | - | -3 t. | -5 t. | -165 t. | 1 |
| 2018 | - | -7 t. | -53 t. | -160 t. | - |
Official annual report
Keep an eye on TREATMENT PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
On September 25, 2022, the company changed its name from TREATMENT ApS to TREATMENT PHARMA ApS.
TREATMENT PHARMA ApS has published its annual report for 2021. Gross profit came to DKK -3,351, and the net result was DKK -2,623.
About TREATMENT PHARMA ApS
TREATMENT PHARMA ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2015. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named TREATMENT ApS. The management consists of Anne Simmenæs. The company is owned by Tove Resen Holding ApS, Power the Future ApS and Anne Simmenæs Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 410,337 and a net result of DKK 101,980 compared with DKK -38,290 the year before. Equity in the 2025 report amounted to DKK 187,516.